Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:affects |
adults
blood infants |
| gptkbp:canBeLifeThreatening |
yes
|
| gptkbp:cause |
gptkb:dapsone
gptkb:phenazopyridine gptkb:primaquine gptkb:hypoxia antimalarial drugs nitrites neurological symptoms phenacetin death (in severe cases) sulfonamides chloroquine nitrobenzene benzocaine chocolate-brown colored blood hereditary enzyme deficiency local anesthetics nitrate-contaminated water reduced oxygen delivery |
| gptkbp:causedBy |
nitrates
aniline dyes certain drugs exposure to oxidizing agents |
| gptkbp:characterizedBy |
elevated methemoglobin levels
|
| gptkbp:diagnosedBy |
blood test
co-oximetry |
| gptkbp:firstDescribed |
1845
|
| gptkbp:hereditaryForm |
gptkb:hemoglobin_M_disease
cytochrome b5 reductase deficiency |
| https://www.w3.org/2000/01/rdf-schema#label |
Methemoglobinemia
|
| gptkbp:ICD-10_code |
D74
|
| gptkbp:inheritance |
yes
|
| gptkbp:inheritedFormCausedBy |
genetic mutations
|
| gptkbp:MeSH_ID |
gptkb:D008766
|
| gptkbp:obtainedFrom |
yes
|
| gptkbp:OMIM |
250800
|
| gptkbp:prevalence |
rare
|
| gptkbp:prevention |
avoiding oxidizing agents
monitoring at-risk patients |
| gptkbp:symptom |
gptkb:arrhythmia
cyanosis dizziness fatigue headache shortness of breath seizures |
| gptkbp:treatment |
gptkb:methylene_blue
ascorbic acid oxygen therapy |
| gptkbp:bfsParent |
gptkb:hemoglobin
|
| gptkbp:bfsLayer |
5
|